American Association for the Advancement of Science, Science Translational Medicine, 433(10), 2018
DOI: 10.1126/scitranslmed.aah5766
Full text: Unavailable
Effective immunity and therapeutic targets are identified with a model of hepatitis B virus clearance and persistence.